According to the Zhitong Finance App, Tianshan Biotech (300313.SZ) released the 2026 Restricted Stock Incentive Plan (draft). The number of restricted shares to be granted to incentive recipients under the incentive plan is 18 million shares, accounting for about 7.51% of the company's total share capital when the draft incentive plan was announced. Of these, 15 million shares were granted for the first time, and 3 million shares were reserved. The award price is 5.64 yuan/share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.